BONE BIOLOGICS CORPORATIONData Transfer Agreement • October 8th, 2015 • Bone Biologics, Corp. • Orthopedic, prosthetic & surgical appliances & supplies
Bone Bio agrees to issue 1,153,846 shares of restricted common stock to the Founders in the percentages set forth on Annex I attached hereto (the “Shares”) on the earlier to occur of (i) the third anniversary of the date hereof and (ii) a “Liquidity Event” which shall mean Bone Bio’s initial public offering or APO/OTCB/PIPE/PPM/PREFERRED CONVERT or sale in exchange for reasonable efforts by Founders to provide the work product and data set forth in Schedule I attached hereto. For transactions and liquidity events that involve customary lockup periods, the Shares shall vest on the expiration date of the lock-up period. The Founders agree to accept the Shares in full satisfaction for the delivery of the Data.
